• Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Leu (c.34_35GG>CT) (c.34_35delinsCT); Zygosity=Homozygous (PubMed=21768923).
  
• Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser127Thr (c.379T>A); ClinVar=VCV000824232; Zygosity=Homozygous (PubMed=21768923).
  

PubMed=21768923; DOI=10.1097/MPA.0b013e3182207a58; PMCID=PMC3180880
Yachida S., Zhong Y., Patrascu R., Davis M.B., Morsberger L.A., Griffin C.A., Hruban R.H., Laheru D., Iacobuzio-Donahue C.A.
Establishment and characterization of a new cell line, A99, from a primary small cell carcinoma of the pancreas.
Pancreas 40:905-910(2011)

DOI=10.4172/2324-9293.1000104
Wagenhauser M.U., Ruckert F., Niedergethmann M., Grutzmann R., Saeger H.-D.
Distribution of characteristic mutations in native ductal adenocarcinoma of the pancreas and pancreatic cancer cell lines.
Cell Biol. Res. Ther. 2:1000104.1-1000104.5(2013)

PubMed=29765522; DOI=10.18632/oncotarget.24930; PMCID=PMC5940407
Ohmoto A., Suzuki M., Takai E., Rokutan H., Fujiwara Y., Morizane C., Yanagihara K., Shibata T., Yachida S.
Establishment of preclinical chemotherapy models for gastroenteropancreatic neuroendocrine carcinoma.
Oncotarget 9:21086-21099(2018)